In tumours with high TOP2A expression, those with concurrent HER2 overexpression showed a higher recurrence rate, and the IC50 in the TOP2A+ HER2+ cells was higher than that in the TOP2A+ HER2- cells. Here, ERBB2 is linked to neoplasm.